Genetic Study Links Higher Omega-3 Levels to Lower Crohn’s Disease Risk

This study used a genetic research method called Mendelian randomization to examine whether naturally occurring differences in blood levels of omega-3 and omega-6 fatty acids relate to the risk of developing Crohn’s disease, a chronic inflammatory bowel condition. Instead of tracking diet or supplement use, researchers used genetic variants linked to fatty acid levels as stand-ins, comparing data from large genetic databases covering over 100,000 people for fatty acid levels and over 40,000 people for Crohn’s disease status.

The analysis found that people with a genetic profile predicting higher circulating omega-3 levels tended to have lower odds of Crohn’s disease. Omega-6 levels alone showed no clear connection either way. However, a higher ratio of omega-6 to omega-3 was linked to increased odds of Crohn’s disease, suggesting the balance between these two fatty acid types may matter more than either one in isolation.

The researchers used several statistical methods to check their results and found no strong signs of bias distorting the findings, though they noted meaningful variability between the genetic markers used, which adds some uncertainty to the conclusions.